| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.002 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.085 | 0.003 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.004 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.084 | 0.005 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |